Drugs / Xianlinggubao
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02455154 Comparator | May 2015 → Feb 2019 | breast cancer, osteoporosis | Shanghai Jiao Tong University School of Medicine | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xianlinggubao | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02455154 ↗ |